Clinical Trials Directory

Trials / Sponsors / Shanghai Zhimeng Biopharma, Inc.

Shanghai Zhimeng Biopharma, Inc.

Industry · 11 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic
ALS (Amyotrophic Lateral Sclerosis)
Phase 2 / Phase 32025-09-29
RecruitingAn Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in Subjects Diagnosed With Epil
Focal Epilepsy
Phase 22025-08-14
Not Yet RecruitingA Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB
Chronic Hepatitis B
Phase 32025-08-01
Not Yet RecruitingA Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients With Focal Epilepsy
Focal Epilepsy
Phase 22024-09-01
CompletedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects W
Chronic Hepatitis b
Phase 12024-04-22
UnknownA Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in
Healthy Volunteers
Phase 12023-09-19
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Aust
Healthy Volunteers
Phase 12022-11-29
UnknownA Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy
Hepatitis B, Chronic
Phase 22022-11-11
UnknownA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
Healthy Volunteers
Phase 12022-05-02
CompletedA Multiple-dose Study in Chinese Subjects to Evaluate Safety,Tolerability,PK and PD of ZM-H1505R
Healthy Volunteers, Hepatitis B, Chronic
Phase 12021-05-27
CompletedA Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single an
Healthy Volunteers
Phase 12020-02-17